POZEN Director Sells $83,800 in Stock (POZN)
POZEN (NASDAQ:POZN) Director Arthur S. Kirsch sold 10,000 shares of POZEN stock on the open market in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $8.38, for a total transaction of $83,800.00. Following the sale, the director now directly owns 26,000 shares in the company, valued at approximately $217,880. The transaction was disclosed in a filing with the SEC, which is available at this link.
POZN has been the subject of a number of recent research reports. Analysts at TheStreet upgraded shares of POZEN from a “sell” rating to a “hold” rating in a research note on Monday, May 12th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $9.92.
Shares of POZEN (NASDAQ:POZN) traded up 3.46% on Tuesday, hitting $8.67. The stock had a trading volume of 395,926 shares. POZEN has a 52-week low of $4.73 and a 52-week high of $9.90. The stock has a 50-day moving average of $8.54 and a 200-day moving average of $8.24. The company’s market cap is $267.5 million.
POZEN (NASDAQ:POZN) last announced its earnings results on Thursday, May 8th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.13. The company had revenue of $7.55 million for the quarter, compared to the consensus estimate of $5.50 million. During the same quarter in the previous year, the company posted ($0.19) earnings per share. The company’s revenue for the quarter was up 433.5% on a year-over-year basis. On average, analysts predict that POZEN will post $0.58 earnings per share for the current fiscal year.
POZEN Inc (NASDAQ:POZN), is a pharmaceutical company focused on transforming medicine.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.